Clinical Trial

Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy Adults

Completed Phase 1
View on ClinicalTrials.gov →
Summary
Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy Adults
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-10-01.
Status change: Not Yet Recruiting → Completed 2026-02-09
Trial Details
NCT Number NCT07213310
Lead Sponsor Daewoong Pharmaceutical Co. LTD.
Conditions Healthy
Enrollment 18 participants
Start Date 2025-11-09
Primary Completion 2026-01-07 (estimated)
Study Completion 2026-01-07 (estimated)
Updated on ClinicalTrials.gov 2026-02-11